Germany, July 16 -- Germany based Gilead Sciences GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement in accordance with Section 130c Paragraph 1 SGB V for the fixed active ingredient combination sofosbuvir/velpatasvir . The value of the contract is not disclosed .
Published by HT Digital Content Services with permission from Pivotal Sources....